FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine, in particular, to pharmaceutics, and deals with pharmaceutical composition, which contains as acting substance therapeutically efficient amount of hydrochloride of 3-(3,4,5-tromethoxybenzoyloxyimino)-8-methyl-8-azabicylo [3,2,1] octane (tropoxin), and as auxiliary substances, at least, one, selected from the group, which includes starch, lactose, microcrystalline cellulose (MCC), ludipress, sodium phosphate twice-substituted, polyvinylpyrrolidone, methylcellulose, carboxymethylcellulose and its sodium salt, oxypropylcellulose, oxypropylmethylcellulose, mannite, sorbite, and, if necessary, stearic acid and/or its salt and/or aerosil Novel composition is represented in two specific versions. Composition is made in form of solid dosed medication, preferably, in form of tablet. Solid dosed drug forms in accordance with invention satisfy all demands of State Pharmacopoeia currently in force.
EFFECT: compositions by invention easily release acting substance, which ensures its high bioavailability.
10 cl, 4 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
ACYLHYDRAZONE (2,3,4-TRIMETHOXY-N'-(8-METHYL-8-AZABICYCLO[3.2.1.]OCTANE-3-YLIDENE) BENZOHYDRAZIDE HYDROCHLORIDE), HAVING ANTIMIGRAINE AND ANXIOLYTIC ACTIVITY | 2016 |
|
RU2699658C2 |
PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC ACTION | 2009 |
|
RU2420304C2 |
ANTIAGGREGANT | 2005 |
|
RU2353363C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2423981C2 |
COMPOUND OF 2,3,4-TRIMETHOXY-N-(2,2,6,6-TETRAMETHYLPIPERIDIN-4-YLIDENE)BENZOHYDRAZIDE HYDROCHLORIDE WITH ANTISEROTONIN CEREBROVASCULAR AND ANTIMIGRAINE ACTIVITY | 2022 |
|
RU2803750C1 |
PHARMACEUTICAL COMPOSITION BASED ON LADASTEN | 2006 |
|
RU2376986C2 |
COMBINATION OF PIPERIDINE DERIVATIVE WITH PICAMILONE, HAVING ANTISEROTONIN AND ANTI-ISCHEMIC ACTIVITY | 2023 |
|
RU2822877C1 |
PHARMACEUTICAL COMPOSITION OF ANTIMIGRAINE ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696866C1 |
HETEROCYCLIC COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS, OR HETEROCYCLIC COMPOUND N-OXIDE, OR ITS ADDITIVE ACID SALT | 1992 |
|
RU2047614C1 |
"NOOPEPT"-BASE PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2289422C2 |
Authors
Dates
2011-07-27—Published
2008-04-07—Filed